About us

Diaxxo is an ETH Zürich spin-off developing a rapid, point-of-care PCR solution that makes molecular diagnostics faster, simpler, and more accessible - especially in settings where traditional lab PCR is too expensive or operationally complex. The company combines a compact PCR device with ready-to-use, preloaded test cartridges that streamline the workflow from sample to result, enabling reliable testing even for non-specialist users. A key business advantage is operational simplicity: reagents are provided in stable, dried form and designed for storage and handling at room temperature, helping reduce cold-chain dependence and lowering total cost of ownership.